COSSA Joins Societies in Requesting Changes to NIH Clinical Trial Policy
In a letter sent to National Institutes of Health (NIH) Director Francis Collins on October 27, COSSA and 21 other scientific societies and associations requested that NIH revisit a new policy that alters the definition of “clinical trials” funded by the agency and institutes new reporting requirements for such research (see COSSA’s coverage of this issue). While the letter is supportive of the goal of enhancing transparency of NIH-funded research, including introducing registration and reporting requirements, the signatories express concern that “basic science research is being redefined as a clinical trial at NIH and that “basic science investigators will be unnecessarily burdened with requirements relating to conducting clinical trials that have nothing to do with their own research.” The organizations hope to work with NIH leadership to find a solution that addresses the concerns of the basic science community while still improving transparency for true clinical trial research.